InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Sukhtian Faisal Ghiath, Director. Officer active across 1 company, notably Outlook Therapeutics, Inc.. In total, 3 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €45k. Activity tracked since 2 December 2021. The latest transaction was disclosed on 2 December 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
27,982,529 sharesCommon StockSEC:0000947871-22-000476:0
18,000 shares@ US$1.400.081% mcap50.0% of flowCommon StockSEC:0001209191-21-067648:0
Ideal exit: 29 Aug 2022 (T+270)
18,000 shares@ US$1.400.081% mcap100.0% of flowCommon StockSEC:0001209191-21-067648
Ideal exit: 29 Aug 2022 (T+270)
3 of 3 declarations
About Sukhtian Faisal Ghiath
Faisal Ghiath Sukhtian is a Board Member at Outlook Therapeutics, Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and overseeing operations. His expertise is valuable in guiding the company's initiatives.
